ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOWA COMPANY, LTD.
  3. Financials
  4. Repayments of term debt

KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
SummaryFinancialsDividendsHistoryWorkforce
Period EndRepayments of term debt (Million JPY)YoY (%)
Mar 31, 2023-63,261+35.38%
Mar 31, 2022-46,727-3.29%
Mar 31, 2021-48,317+3.40%
Mar 31, 2020-46,726+11.44%
Mar 31, 2019-41,930+35.38%
Mar 31, 2018-30,972+25.83%
Mar 31, 2017-24,614+19.90%
Mar 31, 2016-20,528+1.06%
Mar 31, 2015-20,313-25.06%
Mar 31, 2014-27,106+57.57%
Mar 31, 2013-17,202

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat